These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10405547)

  • 21. Shortening duration of treatment of multibacillary leprosy.
    Compostella L
    Indian J Lepr; 1998; 70(2):221-3. PubMed ID: 9724862
    [No Abstract]   [Full Text] [Related]  

  • 22. The difficult decision when to discontinue multidrug therapy in leprosy.
    Kato L
    Acta Leprol; 1987; 5(4):279-82. PubMed ID: 3327350
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
    Sales AM; Sabroza PC; da Costa Nery JA; Duppre NC; Sarno EN
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):320-3. PubMed ID: 15485290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 25 years of MDT: a caveat.
    Soutar D
    Lepr Rev; 2004 Dec; 75(4):406. PubMed ID: 15682979
    [No Abstract]   [Full Text] [Related]  

  • 25. Status of the multibacillary leprosy patients treated with combined regimens of 1 year duration, after a mean follow-up of more than 5 years.
    Pattyn SR; Bourland J; Deverchin J; Ghys P; Grillone S; Groenen G; Janssens L; Kuykens P
    Lepr Rev; 1991 Sep; 62(3):337-9. PubMed ID: 1795593
    [No Abstract]   [Full Text] [Related]  

  • 26. Multidrug therapy in leprosy. WHO Study Group.
    Nurs J India; 1984 Apr; 75(4):83-6, 90. PubMed ID: 6565263
    [No Abstract]   [Full Text] [Related]  

  • 27. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 28. Introduction of multidrug therapy: two points highlighted.
    Tare SP
    Lepr Rev; 1987 Sep; 58(3):309. PubMed ID: 3669873
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of MDT in the three western regions of Nepal.
    Kalthoff PG
    Lepr Rev; 1986; 57 Suppl 3():106-14. PubMed ID: 3573950
    [No Abstract]   [Full Text] [Related]  

  • 30. Relapse following fixed duration treatment for multibacillary leprosy.
    Wkly Epidemiol Rec; 1994 Oct; 69(41):301-2. PubMed ID: 7986699
    [No Abstract]   [Full Text] [Related]  

  • 31. Multidrug therapy in leprosy and its future components.
    Girdhar BK
    Indian J Lepr; 1994; 66(2):179-208. PubMed ID: 7806900
    [No Abstract]   [Full Text] [Related]  

  • 32. A process for planning the introduction and implementation of multidrug therapy for leprosy.
    Ross WF
    Lepr Rev; 1987 Dec; 58(4):313-23. PubMed ID: 3431334
    [No Abstract]   [Full Text] [Related]  

  • 33. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN
    Indian J Lepr; 1998; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract]   [Full Text] [Related]  

  • 34. [Field experiences with therapy protocols in leprosy].
    Pattyn SR
    Verh K Acad Geneeskd Belg; 1983; 45(3):303-14. PubMed ID: 6364614
    [No Abstract]   [Full Text] [Related]  

  • 35. Single-dose treatment for paucibacillary leprosy; field implications.
    Revankar CR; Pai VV; Samy MS; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
    [No Abstract]   [Full Text] [Related]  

  • 36. Single dose 'ROM' therapy--is it really effective?
    Mandal AK
    Natl Med J India; 1998; 11(5):247. PubMed ID: 10997176
    [No Abstract]   [Full Text] [Related]  

  • 37. Ocular findings in leprosy patients in Nepal in the era of multidrug therapy.
    Nepal BP; Shrestha UD
    Am J Ophthalmol; 2004 May; 137(5):888-92. PubMed ID: 15126154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 40. Reasons for interrupting multidrug therapy against leprosy: the patients' point of view.
    Chichava OA; Ariza L; Oliveira AR; Ferreira AC; Da Silva LF; Barbosa AN; Ramos Júnior AN; Heukelbach J
    Lepr Rev; 2011 Mar; 82(1):78-9. PubMed ID: 21644476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.